APA (7th ed.) Citation

Xu, L., Jiang, W., Li, W., Guo, C., Luo, L., Gao, Y., & Cao, Y. (2022). Comparison of a histone deacetylase inhibitor plus exemestane with exemestane alone in hormone receptor-positive advanced breast cancer that progressed on prior endocrine therapy: A meta-analysis. Experimental & Therapeutic Medicine, 24(3), N.PAG. https://doi.org/10.3892/etm.2022.11512

Chicago Style (17th ed.) Citation

Xu, Liang, Weifan Jiang, Wenwei Li, Chungen Guo, Lihua Luo, Yufeng Gao, and Yali Cao. "Comparison of a Histone Deacetylase Inhibitor Plus Exemestane with Exemestane Alone in Hormone Receptor-positive Advanced Breast Cancer That Progressed on Prior Endocrine Therapy: A Meta-analysis." Experimental & Therapeutic Medicine 24, no. 3 (2022): N.PAG. https://doi.org/10.3892/etm.2022.11512.

MLA (9th ed.) Citation

Xu, Liang, et al. "Comparison of a Histone Deacetylase Inhibitor Plus Exemestane with Exemestane Alone in Hormone Receptor-positive Advanced Breast Cancer That Progressed on Prior Endocrine Therapy: A Meta-analysis." Experimental & Therapeutic Medicine, vol. 24, no. 3, 2022, p. N.PAG, https://doi.org/10.3892/etm.2022.11512.